Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

1.

Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.

Hoffman PC, Masters GA, Drinkard LC, Krauss SA, Samuels BL, Golomb HM, Vokes EE.

Semin Oncol. 1996 Jun;23(3 Suppl 6):11-5.

PMID:
8677441
2.

Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.

Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.

Semin Oncol. 1996 Apr;23(2 Suppl 5):11-8.

PMID:
8610230
3.

Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.

Vallejo C, Romero A, Perez J, Cuevas M, Lacava J, Sabatini C, Dominguez M, Rodriguez R, Barbieri M, Romero Acuña L, Romero Acuña J, Langhi M, Amato S, Salvadori M, Ortiz E, Machiavelli M, Leone B.

Am J Clin Oncol. 1996 Dec;19(6):584-8.

PMID:
8931677
4.

Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer.

Shepherd FA, Latreille J, Paul K, Eisenhauer E.

Semin Oncol. 1996 Dec;23(6 Suppl 16):84-90.

PMID:
9007130
5.

Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer.

Hoffman PC, Krauss SA, Drinkard LC, Masters GA, Samuels BL, Bitran JD, Golomb HM, Watson S, Vokes EE.

Semin Oncol. 1995 Aug;22(4 Suppl 9):38-41.

PMID:
7544026
7.

Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.

Souquet PJ, Fournel P, Bohas CH, Fortune IC, Chatte G.

Semin Oncol. 1996 Apr;23(2 Suppl 5):8-10.

PMID:
8610239
8.

Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.

Chang AY, Boros L, Garrow GC, Asbury RF, Hui L.

Semin Oncol. 1996 Jun;23(3 Suppl 6):74-7.

PMID:
8677454
9.

A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.

Strauss GM, Lynch TJ, Elias AD, Jacobs C, Kwiatkowski DJ, Shulman LN, Carey RW, Grossbard ML, Jauss S, Sugarbaker DJ, et al.

Semin Oncol. 1995 Aug;22(4 Suppl 9):70-4.

PMID:
7544029
10.

Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.

Glisson B, Lee JS, Palmer J, Fossella F, Shin DM, Murphy WK, Perez-Soler R, Hong WK.

Cancer. 1998 Jan 15;82(2):301-8.

PMID:
9445186
11.

Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer.

Chang AY, DeVore R, Johnson D.

Semin Oncol. 1996 Apr;23(2 Suppl 5):19-21.

PMID:
8610231
12.

Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.

Strauss GM, Lynch TJ, Elias AD, Jacobs C, Herbst R, Leong T, Lynch C, Kwiatkowski DJ, Carey RW, Grossbard ML, Skarin AT.

Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-73-S12-80.

PMID:
9331127
13.

Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.

Belli L, LeChevalier T, Gottfried M, Adams D, Ruffie P, LeCesne A, Tete L, Pellae-Cosset B.

Semin Oncol. 1995 Dec;22(6 Suppl 15):29-33.

PMID:
8643967
14.

A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.

Masters GA, Mauer AM, Hoffman PC, Wyka D, Samuels BL, Krauss SA, Watson S, Golomb H, Vokes EE.

Ann Oncol. 1998 Jun;9(6):677-80.

PMID:
9681085
15.

Phase I/II trial of paclitaxel and vinorelbine in advanced non-small cell lung cancer.

Grunberg SM, Dugan MC, Greenblatt MS, Ospina DJ, Valentine JW.

Cancer Invest. 2005;23(5):392-8.

PMID:
16193638
16.

Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer.

Drinkard LC, Hoffman PC, Samuels BL, Watson S, Bitran JD, Golomb HM, Vokes EE.

Semin Oncol. 1995 Apr;22(2 Suppl 5):30-7; discussion 41-4.

PMID:
7537911
17.

Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532.

Perry MC, Ihde DC, Herndon JE 2nd, Grossbard ML, Grethein SJ, Atkins JN, Vokes EE, Green MR.

Lung Cancer. 2000 Apr;28(1):63-8.

PMID:
10704711
18.

A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.

Masters GA, Hoffman PC, Drinkard LC, Samuels BL, Golomb HM, Vokes EE.

Semin Oncol. 1998 Feb;25(1 Suppl 2):8-14. Review.

PMID:
9535205
19.
20.

A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.

Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.

Cancer J Sci Am. 1995 Nov-Dec;1(4):288-94.

PMID:
9166490

Supplemental Content

Support Center